New Century Healthcare Holding Co. Limited (HKG:1518)
Hong Kong · Delayed Price · Currency is HKD 0.6500
0.00 (0.00%)
At close: Feb 13, 2026
HKG:1518 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 735.07 | 846.5 | 933.07 | 636.46 | 632.57 | 512.79 | |
Revenue Growth (YoY) | -21.21% | -9.28% | 46.60% | 0.62% | 23.36% | -29.70% |
Cost of Revenue | 469.18 | 501.54 | 525.99 | 434.32 | 433.83 | 377.02 |
Gross Profit | 265.88 | 344.96 | 407.09 | 202.14 | 198.74 | 135.76 |
Selling, General & Admin | 192.1 | 192.73 | 198.15 | 194.11 | 217.24 | 167.34 |
Research & Development | 3.66 | 4.08 | 5.93 | 7.7 | 10.57 | 14.47 |
Other Operating Expenses | 0.31 | -0.39 | -1.95 | -3.29 | -3.66 | -3.78 |
Operating Expenses | 201.87 | 202.22 | 211 | 325.16 | 231.74 | 184.23 |
Operating Income | 64.02 | 142.74 | 196.09 | -123.02 | -33 | -48.47 |
Interest Expense | -6.93 | -7.61 | -8.06 | -10.06 | -13.9 | -15.79 |
Interest & Investment Income | 3.79 | 4.9 | 1.78 | 2.07 | 3.06 | 3.29 |
Earnings From Equity Investments | 1.9 | 2.27 | -0.08 | -0.03 | -0.7 | 0.05 |
Currency Exchange Gain (Loss) | 0.51 | 0.51 | 1.15 | 7.64 | -2.35 | -7.54 |
Other Non Operating Income (Expenses) | -0.5 | -0.5 | -0.46 | -2.97 | -0.4 | - |
EBT Excluding Unusual Items | 62.79 | 142.31 | 190.43 | -126.36 | -47.3 | -68.46 |
Impairment of Goodwill | - | - | - | -33.6 | - | -234.49 |
Gain (Loss) on Sale of Investments | - | - | - | -7.86 | - | -9.17 |
Gain (Loss) on Sale of Assets | -0.77 | -0.77 | -0.72 | 0.07 | 3.16 | 2.1 |
Asset Writedown | -33.74 | - | -23.56 | -122.1 | -15.01 | -19.48 |
Other Unusual Items | - | - | - | - | - | 0.74 |
Pretax Income | 28.29 | 141.54 | 166.14 | -289.85 | -59.15 | -328.75 |
Income Tax Expense | 41.62 | 47.76 | 34.05 | 1.72 | 26.12 | 48.79 |
Earnings From Continuing Operations | -13.33 | 93.78 | 132.09 | -291.57 | -85.26 | -377.53 |
Minority Interest in Earnings | -29.72 | -46.4 | -47.93 | -6.16 | -16.2 | 6.15 |
Net Income | -43.05 | 47.38 | 84.16 | -297.73 | -101.46 | -371.38 |
Net Income to Common | -43.05 | 47.38 | 84.16 | -297.73 | -101.46 | -371.38 |
Net Income Growth | - | -43.71% | - | - | - | - |
Shares Outstanding (Basic) | 483 | 483 | 483 | 483 | 483 | 485 |
Shares Outstanding (Diluted) | 483 | 483 | 483 | 483 | 483 | 485 |
Shares Change (YoY) | - | - | -0.01% | -0.02% | -0.37% | 0.06% |
EPS (Basic) | -0.09 | 0.10 | 0.17 | -0.62 | -0.21 | -0.77 |
EPS (Diluted) | -0.09 | 0.10 | 0.17 | -0.62 | -0.21 | -0.77 |
EPS Growth | - | -43.71% | - | - | - | - |
Free Cash Flow | 57.38 | 114.33 | 149.43 | 66.63 | 11.02 | -15.61 |
Free Cash Flow Per Share | 0.12 | 0.24 | 0.31 | 0.14 | 0.02 | -0.03 |
Dividend Per Share | 0.021 | 0.021 | 0.034 | - | - | - |
Dividend Growth | -39.47% | -39.47% | - | - | - | - |
Gross Margin | 36.17% | 40.75% | 43.63% | 31.76% | 31.42% | 26.48% |
Operating Margin | 8.71% | 16.86% | 21.02% | -19.33% | -5.22% | -9.45% |
Profit Margin | -5.86% | 5.60% | 9.02% | -46.78% | -16.04% | -72.42% |
Free Cash Flow Margin | 7.81% | 13.51% | 16.01% | 10.47% | 1.74% | -3.04% |
EBITDA | 86.17 | 167.02 | 224.04 | -87.54 | 10.22 | -0.53 |
EBITDA Margin | 11.72% | 19.73% | 24.01% | -13.75% | 1.62% | -0.10% |
D&A For EBITDA | 22.15 | 24.28 | 27.95 | 35.48 | 43.22 | 47.94 |
EBIT | 64.02 | 142.74 | 196.09 | -123.02 | -33 | -48.47 |
EBIT Margin | 8.71% | 16.86% | 21.02% | -19.33% | -5.22% | -9.45% |
Effective Tax Rate | 147.13% | 33.74% | 20.50% | - | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.